Related Experiment Videos
HIV disease and respiratory infection in children
Stephen M Graham1, Diana M Gibb
1Wellcome Trust Research Laboratory and Department of Paediatrics, College of Medicine, University of Malawi, Malawi. GrahamSt@sesahs.nsw.gov.au
Insights
Respiratory disease is a major cause of death in children with HIV globally. Prevention strategies are improving in developed nations, but the burden is shifting to non-industrialized countries.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Over one million children worldwide live with HIV, with respiratory disease as the leading cause of illness and death.
- Childhood HIV infection prevention is effective in industrialized nations but lags elsewhere, increasing the disease burden in non-industrialized countries.
- Respiratory infection patterns in children with HIV differ significantly between industrialized and non-industrialized regions.
Purpose of the Study:
- To describe and contrast the patterns of respiratory infection in children living with HIV in industrialized versus non-industrialized countries.
- To highlight the impact of Pneumocystis pneumonia (PCP) prophylaxis and antiretroviral therapy on respiratory infections in resource-rich settings.
- To identify data gaps and emphasize the need for more research in resource-poor regions.
Main Methods:
- This is a review article, synthesizing existing data on respiratory infections in children with HIV.
- Comparative analysis of respiratory infection patterns between industrialized (e.g., UK) and non-industrialized (e.g., tropical Africa) regions.
- Discussion of the influence of medical interventions like PCP prophylaxis and antiretroviral therapy.
Main Results:
- Respiratory infection presentation typically occurs in infancy or early childhood.
- Resource-rich countries show altered patterns due to PCP prophylaxis and antiretroviral therapy.
- Differences in respiratory infection patterns are largely attributed to higher background risks and limited management options in resource-poor settings.
Conclusions:
- The burden of pediatric HIV and associated respiratory diseases is increasingly concentrated in non-industrialized countries.
- While advancements in treatment have changed outcomes in developed nations, significant challenges remain in resource-limited areas.
- Further data from resource-poor regions are crucial for understanding and addressing pediatric HIV-related respiratory morbidity and mortality.
Abstract:
Over one million children world-wide are living with HIV infection and respiratory disease is the commonest cause of morbidity and mortality in these children. The initial presentation of respiratory infection is usually in infancy or early childhood. There is enormous potential to prevent childhood HIV infection that is being realised in industrialised countries but not yet elsewhere. Increasingly, therefore, the burden of HIV disease is in children living in or from non-industrialised countries. This review describes and contrasts the pattern of respiratory infection from both regions. This pattern has changed with the implementation of PCP prophylaxis and the availability of potent antiretroviral therapy for children in resource-rich countries, such as the UK. More data are required from resource-poor regions such as tropical Africa, but it is clear that the major differences reflect greater background risk for respiratory infection and very limited management options rather than specific aetiology.